Document:

EX-10.1

 Exhibit 10.1 

THE SECURITY REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY
APPLICABLE STATE SECURITIES LAW AND HAS BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED
THERETO UNDER THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED. 

 
  

FORM OF INCENTIVE STOCK OPTION AGREEMENT 

Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”), hereby grants to the individual named below an option
(the “Option”) to purchase certain shares of common stock of the Company pursuant to the Aerie Pharmaceuticals, Inc. 2013 Omnibus Incentive Plan, in the manner and subject to the provisions of this Option Agreement. 

 

	1.	Definitions: 

  

	 	(a)	“Code” shall mean the Internal Revenue Code of 1986, as amended. (All citations to Sections of the Code are to such Sections as they may from time to time be amended or renumbered.) 

 

	 	(b)	“Company” shall mean Aerie Pharmaceuticals, Inc., a Delaware corporation, and any successor corporation thereto. 

  

	 	(c)	“Date of Option Grant” shall mean             , 2014. 

  

	 	(d)	“Disability” shall mean disability within the meaning of Section 22(e)(3) of the Code, as determined by the Board of Directors of the Company (the “Board”) in its discretion under
procedures established by the Board. 

  

	 	(e)	“Exercise Price” shall mean                     ($
                ) per share as adjusted from time to time pursuant to the Plan. 

  

	 	(f)	“Number of Option Shares” shall mean                 shares of common stock of the Company as adjusted from time to time
pursuant to the Plan. 

  

	 	(g)	“Option Term Date” shall mean the date ten (10) years after the Date of Option Grant. 

  

	 	(h)	“Optionee” shall mean                     . 

	 	(i)	“Plan” shall mean the Aerie Pharmaceuticals, Inc. Omnibus Incentive Plan. 

  

	2.	Status of the Option. The Option is intended to be an incentive stock option as described in Section 422 of the Code, but the Company does not represent or warrant that the Option qualifies as such. To the
extent that the Option fails to qualify as an incentive stock option, it shall be deemed a nonqualified stock option. The Optionee should consult with the Optionee’s own tax advisors regarding the tax effects of the Option and the requirements
necessary to obtain favorable income tax treatment under Section 422 of the Code. 

  

	3.	Administration. All questions of interpretation concerning the Option shall be determined by the Committee and shall be final and binding upon all persons having an interest in the Option. 

 

	4.	Exercise of the Option. 

  

	 	(a)	Right to Exercise. The Option shall become exercisable as set forth below, subject to the termination provisions of this Agreement and the Optionee’s acknowledgement and agreement that any shares purchased
upon exercise of the Option are subject to the Company’s repurchase rights set forth in the Plan: 

  

	 	(i)	On and after             , 2015, the Option may be exercised to purchase up to 1/4th of the Number of Option Shares. 

 

	 	(ii)	On or after the     th day of each successive month thereafter, the Option may be exercised to purchase up to an additional 1/48th of the Number
of Option Shares. 

  

	 	(iii)	The foregoing provisions shall be interpreted such that on or after            , 2018, the Option may be exercised to purchase up to 100% of the Number of
Option Shares. 

 The schedule set forth above is cumulative, so that shares as to which the Option has become exercisable on
and after a date indicated by the schedule may be purchased pursuant to exercise of the Option at any subsequent date prior to termination of the Option. The Option may be exercised at any time and from time to time to purchase up to the number of
shares as to which it is then exercisable. 
 Notwithstanding the foregoing, if the aggregate fair market value of the stock with respect to
which the Option and any other incentive stock option held by the Optionee may be exercised (determined without regard to this provision) for the first time during any calendar year, as determined as of the Date of Option Grant and (if applicable)
the dates of grant of such other incentive stock options and otherwise in accordance with Section 422(d) of the Code, exceeds One Hundred Thousand Dollars ($100,000), the Option shall be deemed a nonqualified stock option to the extent of such
excess. 

  
 2 

	 	(b)	Method of Exercise. The Option shall be exercised by written notice to the Company in the form of Exhibit A hereto. The written notice must be signed by the Optionee and must be delivered in person or by
certified mail, return receipt requested, to the Chief Financial Officer of the Company accompanied by full payment of the exercise price for the number of shares being purchased. 

 

	 	(c)	Restrictions on Grant of the Option and Issuance of Shares. The grant of the Option and the issuance of the shares upon exercise of the Option shall be subject to compliance with all applicable requirements of
federal or state law with respect to such securities. The Option may not be exercised if the issuance of shares upon such exercise would constitute a violation of any applicable federal or state securities laws or other law or regulations. In
addition, no Option may be exercised unless (i) a registration statement under the Securities Act of 1933, as amended (the “Securities Act”), and any applicable state securities laws shall at the time of exercise of the Option
be in effect with respect to the shares issuable upon exercise of the Option or (ii) in the opinion of legal counsel to the Company, the shares issuable upon exercise of the Option may be issued in accordance with the terms of an applicable
exemption from the registration requirements of the Securities Act and any applicable state securities laws. 

 THE OPTIONEE
IS CAUTIONED THAT THE OPTION MAY NOT BE EXERCISABLE UNLESS THE FOREGOING CONDITIONS ARE SATISFIED. ACCORDINGLY, THE OPTIONEE MAY NOT BE ABLE TO EXERCISE THE OPTION WHEN DESIRED EVEN THOUGH THE OPTION IS EXERCISABLE PURSUANT TO THE TERMS HEREOF.

 As a condition to the exercise of the Option, the Company may require the Optionee to satisfy any qualifications that may be necessary or
appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company. 
  

	 	(d)	Fractional Shares. The Company shall not be required to issue fractional shares upon the exercise of the Option. 

  

	5.	Non-Transferability of the Option. The Option may not be assigned or transferred in any manner except by will or by the laws of descent and distribution. 

 

	6.	Termination of the Option. Subject to Section 8 of this Agreement, the Option shall terminate upon on the first to occur of: (a) the Option Term Date; or (b) the last date for exercising the Option
following termination of employment as described in this Agreement. 

  
 3 

	7.	Termination of Employment. 

  

	 	(a)	Termination of the Option. If the Optionee ceases to be an employee of the Company for any reason except death or Disability, the Option, to the extent exercisable by the Optionee on the date on which the
Optionee ceased to be an employee, may be exercised by the Optionee until the earlier of (i) three (3) months after the date on which the Optionee’s employment terminates or (ii) the Option Term Date. Notwithstanding the
foregoing, if the Optionee’s employment with the Company is terminated for cause (as determined in the sole discretion of the Board unless cause is defined in an employment agreement between the Optionee and the Company in which case such
definition shall be used), the Option may not be exercised after the date on which the Optionee’s employment terminates. If the Optionee’s employment with the Company is terminated because of the death or Disability of the Optionee, the
Option, to the extent exercisable by the Optionee on the date on which the Optionee ceased to be an employee, may be exercised by the Optionee (or the Optionee’s legal representative) until the earlier of (i) the expiration of twelve
(12) months from the date the Optionee’s employment terminated or (ii) the Option Term Date. The Optionee’s employment shall be deemed to have terminated on account of death if the Optionee dies within three (3) months after
the Optionee’s termination of employment. This paragraph shall be interpreted such that the Option shall not become exercisable as to any additional number of Option Shares after the date on which the Optionee ceases to be an employee of the
Company (pursuant to this paragraph) for any reason, notwithstanding any period after such cessation of employment during which the Option may remain exercisable as provided in this paragraph. 

 

	 	(b)	Optionee Subject to Section 16(b). Notwithstanding the foregoing, if the exercise of the Option within the applicable time periods set forth above would subject the Optionee to suit under Section 16(b)
of the Securities Exchange Act of 1934, as amended, the Option shall remain exercisable until the earliest to occur of (i) the tenth (10th) day following the date on which the Optionee would no longer be subject to such suit, (ii) the
one hundred and ninetieth (190th) day after the Optionee’s termination of employment, or (iii) the Option Term Date. 

  

	 	(c)	Leave of Absence. For purposes hereof, the Optionee’s employment with the Company shall not be deemed to terminate if the Optionee takes any military leave, sick leave, or other bona fide leave of absence
approved by the Company of ninety (90) days or less. In the event of a leave in excess of ninety (90) days, the Optionee’s employment shall be deemed to terminate on the ninety-first (91st) day of the leave unless the
Optionee’s right to reemployment with the Company remains guaranteed by statute or contract. 

  

	8.	Corporate Transaction. The provisions of the Plan applicable to a Corporate Transaction (as defined in the Plan) shall apply to the Option. 

  
 4 

	9.	Rights as a Stockholder or Employee. The Optionee shall have no rights as a stockholder with respect to any shares covered by the Option until the date of the issuance of a certificate or certificates for the
shares for which the Option has been exercised. Nothing in the Option shall confer upon the Optionee any right to continue in the employ of the Company or interfere in any way with any right of the Company to terminate the Optionee’s employment
at any time. 

  

	10.	Notice of Sales Upon Disqualifying Disposition. The Optionee shall dispose of the shares acquired pursuant to the Option only in accordance with the provisions of this Option Agreement. In addition, the Optionee
shall promptly notify the Chief Financial Officer or other appropriate officer of the Company if the Optionee disposes of any of the shares acquired pursuant to the Option within one (1) year from the date the Optionee exercises all or part of
the Option or within two (2) years of the date of grant of the Option. Until such time as the Optionee disposes of such shares in a manner consistent with the provisions of this Option Agreement, the Optionee shall hold all shares acquired
pursuant to the Option in the Optionee’s name (and not in the name of any nominee) for the one-year period immediately after exercise of the Option and the two-year period immediately after grant of the Option. At any time during the one-year
or two-year periods set forth above, the Company may place a legend or legends on any certificate or certificates representing shares acquired pursuant to the Option requesting the transfer agent for the Company’s stock to notify the Company of
any such transfers. The obligation of the Optionee to notify the Company of any such transfer shall continue notwithstanding that a legend has been placed on the certificate or certificates pursuant to the preceding sentence. 

 

	12.	Binding Effect. This Option Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, executors, administrators, successors and assigns. 

 

	13.	Termination or Amendment. The Board may terminate or amend this Option Agreement at any time; provided, however, that no such termination or amendment may materially adversely affect the Option or any unexercised
portion hereof, as determined in the discretion of the Board, without the consent of the Optionee unless such amendment is required to enable the Option to qualify as an Incentive Stock Option. 

 

	14.	Integrated Agreement. This Option Agreement, together with the Plan, constitute the entire understanding and agreement of the Optionee and the Company with respect to the subject matter contained herein, and
there are no other agreements, understandings, restrictions, representations, or warranties among the Optionee and the Company with respect to the subject matter contained herein other than those as set forth or provided for herein and therein. To
the extent contemplated herein, the provisions of this Option Agreement shall survive any exercise of the Option and shall remain in full force and effect. The terms and conditions included in the Plan are incorporated by reference herein, and to
the extent that any conflict may exist between any term or provision of this Option Agreement and any term or provision of the Plan, the term or provision of the Plan shall control. 

  
 5 

	15.	Applicable Law. This Option Agreement shall be governed by the laws of the State of Delaware. 

  

	16.	Effect of Certain Transactions. Notwithstanding anything to the contrary in this Option Agreement, in the event that the Optionee has entered into a confidentiality, nondisclosure, invention and/or
non-competition agreement with the Company and the Optionee is determined, in the reasonable judgment of the Company’s Board of Directors, to have materially breached such agreement, the Optionee shall forfeit any shares acquired pursuant to
the Option and 100% of the Option granted pursuant to this Option Agreement, whether or not exercisable. 

  

	17.	Section 409A of the Code. The Exercise Price is intended to be the fair market value of the common stock of the Company on the Date of Option Grant. The Company has determined the fair market value of the
common stock in good faith, in compliance with the applicable provisions of the Code and the regulations thereunder and using the reasonable application of a reasonable valuation method. Notwithstanding this, the Internal Revenue Service may assert
that the fair market value of the common stock on the Date of Option Grant was greater than the Exercise Price. Under Section 409A of the Code, if the Exercise Price is less than the fair market value of the common stock as of the Date of
Option Grant, this Option may be treated as a form of deferred compensation and the Optionee may be subject to an additional twenty percent (20%) tax, plus interest and possible penalties. The Optionee acknowledges that the Company has advised
the Optionee to consult with a tax adviser regarding the potential impact of Section 409A of the Code and that the Company, in the exercise of its sole discretion and without the consent of the Optionee, may amend or modify this Agreement in
any manner and delay the payment of any amounts payable pursuant to this Agreement to the minimum extent necessary to meet the requirements of Section 409A of the Code, as amplified by any Internal Revenue Service or U.S. Treasury Department
regulations or guidance as the Company deems appropriate or advisable. 

  

			
	AERIE PHARMACEUTICALS, INC.
		
	By:	 	  

		 	Richard J. Rubino
		 	Chief Financial Officer

  
 6 

 The Optionee represents that the Optionee is familiar with the terms and provisions of this
Option Agreement, including the right of first refusal set forth in the Plan, and hereby accepts the Option subject to all of the terms and provisions thereof. The Optionee hereby agrees to accept as binding, conclusive and final all decisions or
interpretations of the Board of Directors of the Company made in good faith upon any questions arising under this Option Agreement. 
 The
undersigned hereby acknowledges receipt of a copy of the Plan. 
  

			
	Date:                    	 	  

  
 7 

 EXHIBIT A 

Date:                      

Aerie Pharmaceuticals, Inc. 
 Attn: Chief Financial Officer 

					
	  
	 		 	
	  
	 		 	

  

	 	Re:	Exercise of Incentive Stock Option 

 Dear Sir or Madam: 

Pursuant to the terms and conditions of the Incentive Stock Option Agreement dated as of
            ,         (the “Agreement”), between
                                        
(“Optionee”)                     and
                    Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Optionee hereby agrees to purchase
                shares (the “Shares”) of the Common Stock of the Company and tenders payment in full for such shares in accordance with the terms of the
Agreement. 
 The Shares are being issued to Optionee in a transaction not involving a public offering and pursuant to an exemption from
registration under the Securities Act of 1933, as amended (the “1933 Act”). In connection with such purchase, Optionee represents, warrants and agrees as follows: 

 

	 	1.	The Shares are being purchased for the Optionee’s own account and not for the account of any other person, with the intent of holding the Shares for investment and not with the intent of participating, directly or
indirectly, in a distribution or resale of the Shares or any portion thereof. 

  

	 	2.	The Optionee is not acquiring the Shares based upon any representation, oral or written, by any person with respect to the future value of, or income from, the Shares, but rather upon independent examination and
judgment as to the prospects of the Company. 

  

	 	3.	The Optionee has had complete access to and the opportunity to review all material documents related to the business of the Company, has examined all such documents as the Optionee desired, is familiar with the business
and affairs of the Company and realizes that any purchase of the Shares is a speculative investment and that any possible profit therefrom is uncertain. 

	 	4.	The Optionee has had the opportunity to ask questions of and receive answers from the Company and its executive officers and to obtain all information necessary for the Optionee to make an informed decision with respect
to the investment in the Company represented by the Shares. 

  

	 	5.	The Optionee is able to bear the economic risk of any investment in the Shares, including the risk of a complete loss of the investment, and the Optionee acknowledges that he or she may need to continue to bear the
economic risk of the investment in the Shares for an indefinite period. 

  

	 	6.	The Optionee understands and agrees that the Shares are being issued and sold to the Optionee without registration under any state or federal laws relating to the registration of securities, in reliance upon exemptions
from registration under appropriate state and federal laws based in part upon the representations of the Optionee made herein. 

  

	 	7.	The Company is under no obligation to register the Shares or to comply with any exemption available for sale of the Shares by the Optionee without registration, and the Company is under no obligation to act in any
manner so as to make Rule 144 promulgated under the 1933 Act available with respect to any sale of the Shares by the Optionee. 

  

	 	8.	The Optionee has not relied upon the Company or an employee or agent of the Company with respect to any tax consequences related to exercise of this Option or the disposition of the Shares. The Optionee assumes full
responsibility for all such tax consequences and the filing of all tax returns and elections the Optionee may be required to or find desirable to file in connection therewith. 

 

			
	Signature:	 	  

 
			
		
	Printed Name:	 	
		
	Address:	 	  

		 	  

		 	  

  
 2EX-10.18

 Exhibit 10.18 

ARTISAN PARTNERS FUNDS, INC. 

AMENDED AND RESTATED INVESTMENT ADVISORY AGREEMENT 

Artisan Partners Funds, Inc., a Wisconsin corporation registered under the Investment Company Act of 1940, as amended (“1940 Act”),
as an open-end diversified management investment company (“Artisan Funds”), and Artisan Partners Limited Partnership, a Delaware limited partnership registered under the Investment Advisers Act of 1940, as amended, as an investment adviser
(“Artisan Partners”), in consideration of the mutual covenants herein contained, agree that: 
 1. Engagement of Artisan
Partners.  
 (a) Artisan Partners shall manage the investment and reinvestment of the assets of each series of Artisan Funds listed on Schedule A
hereto (each a “Fund” and together “the Funds”), as may be amended from time to time, subject to such policies as the board of directors of Artisan Funds (the “board”) may determine, for the period and on the terms set
forth in this Amended and Restated Investment Advisory Agreement (the “Agreement”). Artisan Partners shall give due consideration to the investment policies and restrictions and the other statements concerning the Funds in Artisan
Funds’ articles of incorporation, bylaws, and registration statements under the 1940 Act and the Securities Act of 1933 (“1933 Act”) and to the provisions of the Internal Revenue Code applicable to each Fund as a regulated investment
company. Artisan Partners shall be deemed for all purposes to be an independent contractor and not an agent of Artisan Funds or any Fund, and unless otherwise expressly provided or authorized, shall have no authority to act for or represent Artisan
Funds or any Fund in any way. 
 (b) Artisan Partners is authorized to make the decisions to buy and sell portfolio investments, to place each Fund’s
portfolio transactions with broker-dealers, and to negotiate the terms of such transactions, including brokerage commissions on brokerage transactions, on behalf of such Fund. 

Artisan Partners’ primary consideration in effecting a security or other transaction for a Fund will be to obtain best execution for the Fund, taking
into account all factors Artisan Partners deems relevant, including, by way of example, price, the size of the transaction, the nature of the market for the security, the amount of the commission, the timing of the transaction taking into account
market prices and trends, the reputation, experience and financial stability of the broker-dealer involved and the quality of service rendered by the broker-dealer in other transactions. Subject to such policies as the board may determine and
consistent with Section 28(e) of the Securities Exchange Act of 1934, as amended, Artisan Partners shall not be deemed to have acted unlawfully or to have breached any duty created by this Agreement or otherwise solely by reason of its having
caused any Fund to pay a broker-dealer, acting as agent, for effecting a portfolio transaction an amount of commission in excess of the amount of commission another broker-dealer would have charged for effecting that transaction if Artisan Partners
determines in good faith that such amount of commission was reasonable in relation to the value of the brokerage and research services provided by such broker-dealer, viewed in terms of either that particular transaction or Artisan Partners’
overall responsibilities with respect to such Fund and to other clients as to which it exercises investment discretion, and in so doing shall not be required to make any reduction in its investment advisory fees. 

 (c) Artisan Partners may, from time to time, delegate to one or more sub-advisers (each a
“Sub-adviser”) any of Artisan Partners’ duties under this Agreement with respect to any Fund. Any such Sub-adviser shall have all of the rights and powers of Artisan Partners as set forth in this Agreement and as specifically
delegated to it by Artisan Partners with respect to such Fund; provided (i) that Artisan Partners must (A) oversee the provision of delegated services and (B) bear any additional costs for the services provided by any
Sub-adviser and (ii) that no such delegation will relieve Artisan Partners of any of its obligations under this Agreement; and provided further, that the retention (or termination) of any Sub-adviser shall be approved in advance by
(i) the board in conformity with the requirements of the 1940 Act, and (ii) the shareholders of the Fund if required under any applicable provisions of the 1940 Act and the rules and regulations under the 1940 Act, subject to any
applicable guidance or interpretation of the Securities and Exchange Commission or its staff. Artisan Partners will review, monitor and report to the board regarding the performance and investment procedures of any Sub-adviser. A Sub-adviser may be
an affiliate of Artisan Partners. 
 Artisan Partners represents that it will notify Artisan Funds of any change in the membership of
Artisan Partners within a reasonable time after any such change, to the extent required by Section 205(a)(3) of the Advisers Act. 
 2.
Expenses to be Paid by Artisan Partners. Artisan Partners shall furnish to Artisan Funds, at its own expense, office space and all necessary office facilities, equipment and personnel for managing each Fund. Artisan Partners shall also
assume and pay all other expenses incurred by it in connection with managing the assets of each Fund; all expenses of marketing shares of each Fund to the extent that such expenses exceed amounts paid under any plan of distribution of shares
pursuant to Section 12(b) of the 1940 Act; all expenses of placement of securities orders and related bookkeeping; and such portion of all fees, dues and other expenses related to membership of Artisan Funds in any trade association or other
investment company organization as may be determined by the board from time to time. Artisan Partners shall not be obligated to pay any expenses of or for any Fund not expressly assumed by Artisan Partners herein. 

3. Expenses to be Paid by Artisan Funds. Artisan Funds shall pay all expenses of its operation not specifically assumed by
Artisan Partners, including, but not limited to, all charges of depositories, custodians and other agencies for the safekeeping and servicing of its cash, securities and other property and of its transfer agents and registrars and its dividend
disbursing and redemption agents, if any; all expenses associated with daily price computations, including pricing services used in the valuation of securities; all charges of legal counsel and of independent accountants; all compensation of
directors other than those affiliated with Artisan Partners and all expenses incurred in connection with their services to Artisan Funds; all costs of borrowing money; all expenses of publication of notices and reports to its shareholders and to
governmental bodies or regulatory agencies; all expenses of proxy solicitations of the Funds or of the board; all expenses of shareholder meetings; all expenses of typesetting of the Funds’ prospectuses and of printing and mailing copies of the
prospectuses furnished to each then-existing shareholder or beneficial owner; all taxes and fees payable to federal, state or other 

  
 2 

 
governmental agencies, domestic or foreign; all stamp or other taxes; all expenses of printing and mailing certificates for shares of the Funds; all expenses of bond and insurance coverage
required by law or deemed advisable by the board; all expenses of qualifying and maintaining qualification of shares of the Funds under the securities laws of such United States and non-United States jurisdictions as Artisan Funds may from time to
time reasonably designate; all expenses of maintaining the registration of Artisan Funds under the 1933 Act and the 1940 Act; and such portion of all fees, dues and other expenses related to membership of Artisan Funds in any trade association or
other investment company organization as may be determined by the board from time to time. In addition to the payment of expenses, the Funds also shall pay all brokers’ commissions and other charges relating to the purchase and sale of
portfolio securities for the Funds. Any expenses borne by Artisan Funds that are attributable solely to the operation or business of any particular Fund shall be paid solely out of such Fund’s assets. Any expenses borne by Artisan Funds that
are not solely attributable to any particular Fund shall be apportioned in such manner as Artisan Partners determines is fair and appropriate, or as otherwise specified by the board. 

4. Compensation of Artisan Partners. For the services to be rendered and the charges and expenses to be assumed and to be paid
by Artisan Partners hereunder, each Fund shall pay to Artisan Partners a monthly fee at the annual rate set forth in Schedule A hereto based on such Fund’s average daily net assets. If Artisan Partners shall serve for less than the whole of a
month, the foregoing compensation shall be prorated. 
 5. Services of Artisan Partners Not Exclusive. The services of Artisan
Partners (and any person controlled by or under common control with Artisan Partners) to Artisan Funds hereunder are not to be deemed exclusive, and Artisan Partners (and any person controlled by or under common control with Artisan Partners) shall
be free to render similar services to others so long as its services under this Agreement are not impaired by such other activities. 
 6.
Services Other Than as Investment Adviser. Artisan Partners (or an affiliate of Artisan Partners) may act as broker for any Fund in connection with the purchase or sale of securities by or to such Fund if and to the extent permitted by
procedures adopted from time to time by the board. Such brokerage services are not within the scope of the duties of Artisan Partners under this Agreement, and, within the limits permitted by law and the board, Artisan Partners (or an affiliate of
Artisan Partners) may receive brokerage commissions, fees or other remuneration from such Fund for such services in addition to its fee for services as an investment adviser pursuant to this Agreement. Within the limits permitted by law, Artisan
Partners may receive compensation from any Fund for other services performed by it for such Fund which are not within the scope of the duties of Artisan Partners under this Agreement. 

7. Limitation of Liability of Artisan Partners. Artisan Partners shall not be liable to Artisan Funds or its shareholders for
any loss suffered by Artisan Funds or its shareholders from or as a consequence of any act or omission of Artisan Partners, or of any of the partners, employees or agents of Artisan Partners, in connection with or pursuant to this Agreement, except
by reason of willful misfeasance, bad faith or gross negligence on the part of Artisan Partners in the performance of its duties or by reason of reckless disregard by Artisan Partners of its obligations and duties under this Agreement. 

  
 3 

 8. Duration and Renewal. This Agreement is effective upon its execution. Unless
terminated as provided in Section 9 of this Agreement, this Agreement shall continue in effect through June 30, 2015, and thereafter from year to year only so long as such continuance is specifically approved at least annually (a) by a
majority of those directors who are not interested persons of Artisan Funds or of Artisan Partners, voting in person at a meeting called for the purpose of voting on such approval, and (b) by either the board or vote of the holders of a
“majority of the outstanding shares of the Fund”; provided, however, that if the continuance of this Agreement is submitted to the shareholders of a Fund for their approval and such shareholders fail to approve such continuance of this
Agreement as provided herein, Artisan Partners may continue to serve hereunder as investment adviser to such Fund in a manner consistent with the 1940 Act and the rules and regulations under the 1940 Act, subject to any applicable guidance or
interpretation of the Securities and Exchange Commission or its staff. 
 9. Termination. This Agreement may be terminated as
to any Fund at any time, without payment of any penalty, by the board or by vote of the holders of a majority of the outstanding shares of such Fund, upon 60 days’ written notice, delivered or mailed by registered mail, postage prepaid, to
Artisan Partners. This Agreement may be terminated as to any Fund by Artisan Partners at any time, without payment of any penalty, upon 60 days’ written notice, delivered or mailed by registered mail, postage prepaid, to Artisan Funds. This
Agreement shall terminate automatically, without payment of any penalty, in the event of its assignment, provided that no delegation of responsibilities by Artisan Partners pursuant to Section 1(c) of this Agreement shall be deemed to
constitute an assignment. The termination of this Agreement with respect to any one Fund shall not be deemed to terminate this Agreement with respect to any other Fund. 

10. Amendment. This Agreement may not be amended orally, but only by an instrument in writing signed by the party against which
enforcement of the amendment is sought. No amendment to this Agreement shall become effective until approved in a manner consistent with the 1940 Act, the rules and regulations thereunder and any applicable guidance or interpretation of the
Securities and Exchange Commission or its staff. 
 11. Definitions. 

For the purposes of this Agreement, the term “a majority of the outstanding shares of the Fund” will be construed in accordance with
the definition of “vote of a majority of the outstanding voting securities of a company” in Section 2(a)(42) of the 1940 Act. 

For the purposes of this Agreement, the terms “affiliated person,” “control,” “interested person” and
“assignment” have their respective meanings defined in the 1940 Act, subject, however, to the rules and regulations under the 1940 Act and any applicable guidance or interpretation of the Securities and Exchange Commission or its staff;
the term “approve at least annually” will be construed in a manner consistent with the 1940 Act and the rules and regulations under the 1940 Act and any applicable guidance or interpretation of the Securities and Exchange Commission or its
staff; and the term “brokerage and research services” has the meaning given in the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder and under any applicable guidance or interpretation of the Securities
and Exchange Commission or its staff. 

  
 4 

 Dated: March 12, 2014 

IN WITNESS WHEREOF, ARTISAN PARTNERS FUNDS, INC. and ARTISAN PARTNERS LIMITED PARTNERSHIP have each caused this agreement to be signed on its behalf by its
duly authorized representative, all as of the date above. 
  

			
	Artisan Partners Funds, Inc.
		
	By:	 	 /s/ Sarah A. Johnson

  

			
	Artisan Partners Limited Partnership
		
	By:	 	 /s/ Sarah A. Johnson

  
 5 

 Schedule A 

 

					
	 Fund
	  	Annual Rate of Fee	 	 Asset Base

	 Emerging Markets Fund
	  	1.050%
1.025%
1.000%
0.975%
0.950%	 	 up to $1 billion
 $1
billion up to $2 billion
 $2 billion up to $3.5 billion

$3.5 billion up to $5 billion
 over $5
billion

			
	 Global Equity Fund
	  	1.000%
0.975%
0.950%
0.925%
0.900%	 	 up to $1 billion
 $1 billion up to $4
billion
 $4 billion up to $8 billion

$8 billion up to $12 billion
 over $12
billion

			
	 Global Opportunities Fund
	  	0.900%
0.875%
0.850%
0.825%
0.800%	 	 up to $1 billion
 $1 billion up to $4
billion
 $4 billion up to $8 billion

$8 billion up to $12 billion
 over $12
billion

			
	 Global Small Cap Fund
	  	1.000%	 	All assets
			
	 Global Value Fund
	  	1.000%
0.975%
0.950%
0.925%
0.900%	 	 up to $1 billion
 $1 billion up to $4
billion
 $4 billion up to $8 billion

$8 billion up to $12 billion
 over $12
billion

			
	 High Income Fund
	  	0.725%
0.700%
0.675%
0.650%
0.625%	 	 up to $1 billion
 $1 billion up to $2
billion
 $2 billion up to $3.5 billion

$3.5 billion up to $10 billion
 over $10
billion

			
	 International Fund
	  	1.000%
0.975%
0.950%
0.925%
0.900%	 	 up to $500 million

$500 million up to $750 million
 $750
million up to $1 billion
 $1 billion up to $12 billion
 over
$12 billion

			
	 International Small Cap Fund
	  	1.250%	 	All assets
			
	 International Value Fund
	  	1.000%
0.975%
0.950%
0.925%	 	 up to $500 million

$500 million up to $750 million
 $750
million up to $1 billion
 over $1 billion

			
	 Mid Cap Fund
	  	1.000%
0.975%
0.950%
0.925%	 	 up to $500 million

$500 million up to $750 million
 $750
million up to $1 billion
 over $1 billion

			
	 Mid Cap Value Fund
	  	1.000%
0.975%
0.950%
0.925%	 	 up to $500 million

$500 million up to $750 million
 $750
million up to $1 billion
 over $1 billion

			
	 Small Cap Fund
	  	1.000%
 0.975%

0.950%
 0.925%
	 	 up to $500 million

$500 million up to $750 million
 $750
million up to $1 billion
 over $1 billion

  
 6 

					
			
	 Small Cap Value Fund
	  	1.000%
 0.975%

0.950%
 0.925%
	 	 up to $500 million

$500 million up to $750 million
 $750
million up to $1 billion
 over $1 billion

			
	 Value Fund
	  	0.800%
 0.760%

0.720%
 0.680%

0.640%
	 	 up to $50 million

$50 million up to $ 100 million

$100 million up to $500 million
 $500
million up to $7.5 billion
 over $7.5 billion

  
 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}]]